State Medical Boards Emphasize Human Accountability for AI in Clinical Practice

What this means for your practice

For telehealth, medspas, dental practices, chiropractic offices, and other healthcare businesses integrating AI tools, this guidance underscores a critical compliance principle: human oversight and accountability are paramount. Practitioners must ensure that AI systems are used to augment, not replace, clinical judgment, and that clear lines of responsibility are maintained. This means developing robust internal policies for AI integration, ensuring adequate clinician training, meticulous documentation of AI-assisted decisions, and adherence to ethical standards. Any practice relying on AI for diagnosis, treatment recommendations, or administrative tasks must recognize that the ultimate legal and ethical responsibility rests with the licensed professional. Practices should also monitor state-specific definitions of the 'practice of medicine' as they may evolve to address AI's role.

Washington, D.C. – As artificial intelligence (AI) rapidly integrates into various aspects of healthcare, the Federation of State Medical Boards (FSMB), which represents all 69 state and territorial medical boards, has articulated a clear stance: AI should be governed within existing professional and institutional accountability structures, with responsibility remaining firmly with the licensed human clinician.

This position, outlined in a recent opinion from FSMB leadership, addresses the burgeoning discussion around whether AI should be licensed to practice medicine independently. The FSMB's perspective highlights that medicine is founded on a social contract where society grants physicians privileges in exchange for extraordinary duties of competence, ethics, and accountability. A medical license, therefore, is tied to human judgment, professional accountability, discipline, transparency, and an unwavering duty to prioritize patients.

AI as a Tool, Not a Practitioner

The FSMB views generative AI as a powerful tool. However, it explicitly states that AI is not ready to be independently licensed like a physician. State medical boards are statutorily charged with licensing and regulating physicians and protecting the public; they are not equipped or designed to regulate machines or tools.

This framework ensures that as AI systems become more autonomous, the ultimate responsibility for harms caused by inappropriate reliance on AI continues to rest with the physician licensee. The FSMB's role is to assist state boards in navigating this evolving landscape, ensuring that regulation keeps pace with innovation while promoting consistent, ethical standards for AI's incorporation into clinical practice.

FSMB's 2024 Policy Guidance

In 2024, the FSMB's House of Delegates adopted nonbinding policy guidance regarding the responsible integration of AI into clinical practice. This guidance, intended for both medical regulators and licensed clinicians, is designed to be comprehensive, balanced, and practical. Key tenets include:

• Encouragement of AI Use: Physicians are encouraged to use AI when it can genuinely improve patient care.
• Documentation: Documentation of AI use in clinical practice is advised.
• Professional Responsibility: The professional responsibility for patient outcomes always remains with the licensed clinician, regardless of AI involvement.

This policy underscores the principle that human oversight is indispensable, and that AI should serve as an aid to the physician, not a replacement for their judgment and accountability.

Emerging Regulatory Landscape and Real-World Examples

The discussion around AI licensing is not theoretical; it is manifesting in policy debates and legislative proposals at the state level. For instance, proposed legislation in Idaho and Iowa this year explored the possibility of creating state licensing boards for 'autonomous service providers' separate from existing medical boards. Both bills ultimately failed, yet their introduction highlights the urgent need for clear regulatory guidance.

Recent events in Utah further illustrate the complexities and the necessary interplay between innovation and traditional medical regulation. The state’s Office of Artificial Intelligence Policy approved a 12-month pilot program with a health tech startup, Doctronic, to automate routine, guideline-based prescription renewals for 192 common drugs under strict parameters and physician oversight. This initiative drew the attention of Utah’s medical licensing board, reinforcing the fact that even when innovation proceeds through state AI-specific frameworks or 'sandboxes,' medical boards must be involved when clinical decisions and patient safety are at stake.

The FSMB's 2024 policy explicitly advised states exploring AI applications in healthcare to collaborate closely with their medical boards. Furthermore, it recommended that medical boards examine how the 'practice of medicine' is defined within their jurisdictions, especially as AI systems gain more autonomy. The FSMB has offered its resources to work with state boards in developing such crucial guidance.

Conclusion

The prevailing message from the FSMB is clear: innovation and oversight must go hand-in-hand. While well-governed AI tools hold significant potential to alleviate administrative burdens, improve access to care, and enable clinicians to dedicate more time to patients, they must be integrated within a framework that prioritizes patient safety and maintains clear lines of accountability. The ultimate responsibility for clinical decisions and patient care, even with advanced AI assistance, remains with the licensed human practitioner.

Key Facts

| Detail | Value | |---|---| | Source of Guidance | Federation of State Medical Boards (FSMB) | | Core Principle | Responsibility for AI in clinical practice remains with the licensed human clinician. | | FSMB Policy Adoption | 2024 (nonbinding policy guidance) | | Legislative Attempts Mentioned | Idaho and Iowa (failed bills to license 'autonomous service providers') | | Pilot Program Example | Utah's Doctronic pilot for automated prescription renewals | | FSMB Role | Advises 69 state and territorial medical boards on consistent, ethical standards for AI. |

Frequently Asked Questions

Can AI be licensed as an independent medical practitioner according to the FSMB?

No, the Federation of State Medical Boards (FSMB) believes that AI is not ready to be independently licensed like a physician. They assert that medicine rests on human judgment and accountability.

Who is responsible if an AI tool makes an error in patient care or provides an inappropriate recommendation?

The professional responsibility for patient outcomes remains with the licensed human clinician who uses the AI tool. State medical boards regulate physicians, not machines, and hold the licensee accountable.

What guidance does the FSMB offer to states exploring AI applications in healthcare?

The FSMB advises states to work closely with their medical boards and to examine how the 'practice of medicine' is defined in their jurisdictions, especially as AI systems become more autonomous.

Does the FSMB encourage or discourage the use of AI in medical practice?

The FSMB encourages the use of AI by physicians when it can improve patient care. However, it also advises documentation of its use and cautions that professional responsibility remains with the licensee.

Are there any examples of state-level discussions or pilots involving AI in medicine?

Yes, proposed legislation in Idaho and Iowa explored licensing autonomous service providers (though these bills failed), and Utah's Office of Artificial Intelligence Policy approved a pilot with Doctronic for automated prescription renewals, which drew the attention of Utah's medical licensing board.

Source: statnews.com — Federal DEA Rules Govern Telemedicine Prescribing of Controlled Substances